Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

Clinical trial NCT02378961 · COMPLETED

Trial details

NCT number

NCT02378961

Sponsor

Gilead Sciences

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2015-02-16

Primary completion

2015-09-21

Enrollment

128

View on ClinicalTrials.gov